BR0214775A - Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos - Google Patents

Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos

Info

Publication number
BR0214775A
BR0214775A BR0214775-0A BR0214775A BR0214775A BR 0214775 A BR0214775 A BR 0214775A BR 0214775 A BR0214775 A BR 0214775A BR 0214775 A BR0214775 A BR 0214775A
Authority
BR
Brazil
Prior art keywords
cis
fused
dibenzo
tetrahydro
preparation
Prior art date
Application number
BR0214775-0A
Other languages
English (en)
Inventor
Hua Mao
Tomasz Kozlecki
Frans Josef Cornel Compernolle
Georges Joseph Corne Hoornaert
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR0214775A publication Critical patent/BR0214775A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

"PREPARAçãO DE DERIVADOS DE 3,3a,8,12b-TETRAIDRO-2H-DIBENZO[3,4:6,7]CICLOHEPTA[1,2- b]FURANO CIS-FUNDIDOS". A presente invenção refere-se a um processo para preparação de cada dos 4 diastereómeros individuais de fórmula (I) em forma estereoquimicamente pura de um precursor enantiomericamente puro simples. O sistema de anel tetracíclico tendo anéis de sete membros e cinco cis-fundidos é formado em uma reação de ciclização de base catalisada. A invenção ainda refere-se aos intermediários de álcool tetracíclicos cis-fundidos desse modo obtidos e produtos finais de metanamina, e os produtos finais de metanamina para uso como um medicamento, em particular como medicamentos ativos de CNS.
BR0214775-0A 2001-12-07 2002-12-02 Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos BR0214775A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204962 2001-12-07
PCT/EP2002/013561 WO2003048147A2 (en) 2001-12-07 2002-12-02 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES

Publications (1)

Publication Number Publication Date
BR0214775A true BR0214775A (pt) 2004-11-09

Family

ID=8181461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214775-0A BR0214775A (pt) 2001-12-07 2002-12-02 Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos

Country Status (16)

Country Link
US (1) US7205335B2 (pt)
EP (1) EP1463722A2 (pt)
JP (1) JP2005511692A (pt)
KR (1) KR20050044334A (pt)
CN (1) CN1697833A (pt)
AU (1) AU2002352205A1 (pt)
BR (1) BR0214775A (pt)
CA (1) CA2468040A1 (pt)
HR (1) HRP20040489A2 (pt)
HU (1) HUP0402325A2 (pt)
IL (1) IL162350A0 (pt)
MX (1) MXPA04005399A (pt)
NO (1) NO20042883L (pt)
PL (1) PL370440A1 (pt)
WO (1) WO2003048147A2 (pt)
ZA (1) ZA200404392B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402152A3 (en) * 2001-12-07 2007-03-28 Janssen Pharmaceutica Nv Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
CN100591652C (zh) * 2004-08-31 2010-02-24 詹森药业有限公司 生产2-（4-氟-苄基）-苯基-乙酸的方法
CA2588760C (en) 2004-12-07 2014-05-13 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
AU2006259020C1 (en) 2005-06-17 2012-01-19 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
PT2874607T (pt) 2012-07-17 2017-08-14 Dow Global Technologies Llc Resumo
WO2014014753A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0892793T1 (en) * 1996-04-12 2003-10-31 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran derivatives
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі

Also Published As

Publication number Publication date
US7205335B2 (en) 2007-04-17
EP1463722A2 (en) 2004-10-06
MXPA04005399A (es) 2004-10-11
HUP0402325A2 (hu) 2005-02-28
WO2003048147A2 (en) 2003-06-12
IL162350A0 (en) 2005-11-20
CA2468040A1 (en) 2003-06-12
HRP20040489A2 (en) 2005-04-30
CN1697833A (zh) 2005-11-16
PL370440A1 (en) 2005-05-30
WO2003048147A3 (en) 2004-04-01
JP2005511692A (ja) 2005-04-28
KR20050044334A (ko) 2005-05-12
AU2002352205A1 (en) 2003-06-17
US20050033067A1 (en) 2005-02-10
NO20042883L (no) 2004-07-07
ZA200404392B (en) 2005-09-27

Similar Documents

Publication Publication Date Title
Omura et al. Pyripyropenes, highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus
CA2386850C (en) Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
BR9915158A (pt) Método para preparação de citalopram
WO2003029199A1 (fr) Derives de benzene et procede de preparation et d'utilisation associe
FR2818642B1 (fr) Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
BRPI0507604A (pt) medicamentos com atividade de receptor hm74a
KR910002444A (ko) 스피로사이클릭 피페리딘 유도체, 이의 제조방법, 이의 용도 및 이를 함유하는 약학 조성물
BG105692A (en) Method for the preparation of 5-cyanophthalide
BR0214775A (pt) Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos
TNSN07485A1 (fr) Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique
HK1076461A1 (en) Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives
BRPI0417520A (pt) 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon
ES8705874A1 (es) Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii
CY1114936T1 (el) Μονοενυδρο παραγωγο ναφθυριδινης και μεθοδος για την παραγωγη του ιδιου
ES2189730T3 (es) Derivados policiclicos aza-indolinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CA2157668A1 (en) Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation
ATE44280T1 (de) Trizyklische verbindungen, verfahren zur herstellung derselben, pharmazeutische praeparate und behandlungsmethode.
DOP2002000519A (es) Procedimiento para la preparación de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal
HUP0204187A3 (en) Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram
WO2005046608A3 (en) Novel compound, corresponding compositions, preparation and/or treatment methods
EP1258478A4 (en) PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS
AR035660A1 (es) Compuestos 3,10-dibromo-8-cloro-11h-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilos o sus sales farmaceuticamente aceptables, composiciones farmaceuticas que los comprenden, usos de los mismos para preparar medicamentos, y un procedimiento para producir un compuesto intermediario para produ
WO2000028019A3 (en) Antisense oligomer
이선아 et al. Further functionalization of the tricyclic intermediate for the synthesis of Harringtonolide
GT199900118A (es) Derivados de pirazol substituido.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.